International Biotechnology Trust plc (IBT) — Strategic Asset Allocation Index
International Biotechnology Trust plc (IBT) has a Strategic Asset Allocation Index of 107.8% as of August 2025. Strategic assets (PP&E of GBX- plus long-term investments of GBX268.92 Million) total GBX268.92 Million, measured against net assets of GBX249.41 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
International Biotechnology Trust plc Strategic Asset Allocation Index (2014–2025)
This chart shows how International Biotechnology Trust plc's Strategic Asset Allocation Index has evolved across 12 annual periods from 2014 to 2025. As of August 2025, the index stands at 107.8%, representing strategic assets of GBX268.92 Million against net assets of GBX249.41 Million GBX. Explore IBT cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for International Biotechnology Trust plc (2014–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for International Biotechnology Trust plc from 2014 to 2025, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see IBT market cap.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 107.8% | GBX268.92 Million | GBX- | GBX268.92 Million | GBX249.41 Million | ▲ +2.4 pp |
| 2024 | 105.4% | GBX297.51 Million | GBX- | GBX297.51 Million | GBX282.26 Million | ▼ -6.3 pp |
| 2023 | 111.7% | GBX301.90 Million | GBX- | GBX301.90 Million | GBX270.32 Million | ▲ +1.7 pp |
| 2022 | 110.0% | GBX313.43 Million | GBX- | GBX313.43 Million | GBX284.89 Million | ▲ +3.4 pp |
| 2021 | 106.7% | GBX345.34 Million | GBX- | GBX345.34 Million | GBX323.77 Million | ▲ +0.2 pp |
| 2020 | 106.5% | GBX302.22 Million | GBX- | GBX302.22 Million | GBX283.90 Million | ▲ +7.9 pp |
| 2019 | 98.6% | GBX237.36 Million | GBX- | GBX237.36 Million | GBX240.82 Million | ▼ -1.6 pp |
| 2018 | 100.2% | GBX263.02 Million | GBX- | GBX263.02 Million | GBX262.47 Million | ▼ -6.4 pp |
| 2017 | 106.6% | GBX269.37 Million | GBX- | GBX269.37 Million | GBX252.65 Million | ▲ +4.2 pp |
| 2016 | 102.4% | GBX221.79 Million | GBX- | GBX221.79 Million | GBX216.65 Million | ▼ -2.3 pp |
| 2015 | 104.6% | GBX246.93 Million | GBX- | GBX246.93 Million | GBX236.00 Million | ▲ +0.1 pp |
| 2014 | 104.5% | GBX224.72 Million | GBX- | GBX224.72 Million | GBX214.97 Million | — |